Mallinckrodt Pharmaceuticals is a $2.2 billion global company that develops, manufactures, markets and distributes specialty pharmaceutical products, contrast media and nuclear imaging agents.
Our specialty pharmaceutical products are sold to major wholesalers and retail drugstore chains. We use our active pharmaceutical ingredients products in the manufacture of our generic pharmaceuticals and also sell them to other pharmaceutical companies. We market our global medical imaging products primarily to physicians, technologists and purchasing administrators at hospitals, imaging centers, cardiology clinics and radiopharmacies.
WE STRIVE TO MAKE COMPLEX PRODUCTS SIMPLER, BETTER AND SAFER FOR PATIENTS.
We are driven by a new energy, led by highly motivated people, and this forward momentum promises to expand our horizons even farther.